Task X3: Evaluation of Clinical Samples from Influenza Clinical Trials

任务 X3：流感临床试验临床样本的评估

• 批准号: 9915369
• 负责人: CAROL SABOURIN
• 金额: $ 36.3万
• 依托单位: BATTELLE CENTERS/PUB HLTH RES & EVALUATN
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-04-05 至 2021-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9915369
• 关键词: Biological; Birds; Clinical; Clinical Trials; Communicable Diseases; Contracts; Development; Feasibility Studies; Influenza; Influenza A Virus, H5N1 Subtype; Influenza A virus; Manufactured Materials; Sampling; Services; Testing; Toxicity Tests; Vaccines; assay development; efficacy testing; evaluation/testing; flu; immunogenicity; novel vaccines; product development; research clinical testing; safety testing; testing services; vaccine development

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.

传染病疫苗和其他生物制品的评估和测试服务（ETS）合同提供从早期可行性研究到材料制造的各种产品开发服务，包括分析开发；免疫原性和有效性试验；临床和非临床样品检测；以及安全性和毒性测试。这些服务将促进开发和引进针对各种传染病的新疫苗和生物制剂。